Eledon Pharmaceuticals Announces First Participant Dosed in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Rejection in Kidney Transplantation
September 05, 2023 07:00 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the first participant has been dosed in the Company’s Phase 2 BESTOW trial...
Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation
August 16, 2023 07:00 ET
|
Eledon Pharmaceuticals, Inc.
10th patient dosed marks achievement of first clinical milestone associated with next tranche of funding Eledon to report updated interim clinical data from the ongoing Phase 1b trial of tegoprubart...
Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results
August 10, 2023 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Ninth patient dosed in ongoing Phase 1b trial evaluating tegoprubart in patients undergoing kidney transplantation; updated clinical data expected in the fourth quarter Raised up to $185 million,...
American Kidney Fund Announces $250,000 Grant from the Robert I. Schattner Foundation in Support of Pediatric Kidney Disease Programs and Safety Net Grants
July 05, 2023 09:11 ET
|
American Kidney Fund
ROCKVILLE, Md., July 05, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce a $250,000 grant from the Robert I. Schattner Foundation, a private charitable foundation...
Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference
June 02, 2023 08:00 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., June 02, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will present...
American Kidney Fund Activates Disaster Relief Program to Support Dialysis and Post-Transplant Patients Affected by Typhoon Mawar
May 25, 2023 09:03 ET
|
American Kidney Fund
ROCKVILLE, Md., May 25, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has turned on its Disaster Relief Program to administer emergency grants to dialysis and post-transplant patients who...
American Kidney Fund’s Kidney Action Summit Brings AKF Ambassadors to Capitol Hill to Urge Congress to Protect Living Donors and Boost Funding for Kidney Disease Research
May 16, 2023 08:30 ET
|
American Kidney Fund
ROCKVILLE, Md., May 16, 2023 (GLOBE NEWSWIRE) -- More than two dozen American Kidney Fund (AKF) Ambassadors – kidney patients, caregivers and living donors from across the country – will meet with...
Eledon Pharmaceuticals Reports First Quarter 2023 Operating and Financial Results
May 11, 2023 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Reported open-label data from ongoing Phase 1b trial of tegoprubart in kidney transplantation demonstrating mean eGFRs from 3 participants above 70 mL/min/1.73m2 at measured timepoints Completed...
American Kidney Fund Will Host Cystinosis Camp as Part of National Virtual Camp for Children and Teens with Kidney Disease
May 08, 2023 09:33 ET
|
American Kidney Fund
ROCKVILLE, Md., May 08, 2023 (GLOBE NEWSWIRE) -- This fall, the American Kidney Fund will be offering special programming specifically for children with cystinosis during its much-loved national...
Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
May 04, 2023 16:05 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that it plans to release financial results for the first quarter ended March...